OSTEOLABS
DEAD

Serial Number

79335785

Owner

osteolabs GmbH

Attorney

Nicholas D. Wells

Filing Date

Dec 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

OSTEOLABS Trademark

Serial Number: 79335785

OSTEOLABS is a trademark filed by osteolabs GmbH on December 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

osteolabs GmbH

Wischhofstraße 1-3,

Entity Type: 99

Trademark Details

Filing Date

December 8, 2021

Registration Date

Not Registered

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 14, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 11, 2023 OPNX
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 28, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 28, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 28, 2023 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 23, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 23, 2023 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2023 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Feb 4, 2023 NREP
REFUSAL PROCESSED BY IB
Dec 5, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 16, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 17, 2022 REPR